Hans-Georg Lerchen is Chief Scientific Officer at Vincerx Pharma. Before joining Vincerx, he was a Distinguished Fellow in the the Pharmaceuticals R&D organization of Bayer AG. With a 33-year background in MedChem he is author or co-author of 81 patents or patent applications and 26 publications. Focus of current research of his team is to expand Vincerx’s bioconjugation platform.